1-2 of 2
Heike Pfeiffer, MD
Close
Sort by
Journal Articles

Multi-Genomics of Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia Reveals Three Distinct Genetic Clusters Characterized By Different Alterations

Michael P Schroeder, PhD, Martin Neumann, MD, Cornelia Eckert, PhD, Lorenz Bastian, MD, Alva Rani James, Nicola Gökbuget, MD, Cornelia Schlee, Jutta Ortiz Tanchez, Konstandina Isaakidis, Stefan Schwartz, MD, Thomas Burmeister, MD, Dieter Hoelzer, MD, Heike Pfeiffer, MD, Michael A Rieger, PhD, Stefanie Göllner, PhD, Thomas Oellerich, MD, Diego Yepes, PhD, Renate Kirschner-Schwabe, PhD, Monika Brüggemann, MD PhD, Carsten Müller-Tidow, Hubert Serve, MD, Claudia D. Baldus, MD
Journal: Blood
Blood (2016) 128 (22): 453.
https://doi.org/10.1182/blood.V128.22.453.453
Published: 2016
Journal Articles

CD19/CD3 Bispecific Antibody Blinatumomab (MT-103) Is Highly Effective In Treatment of Patients with Minimal Residual Disease From Chemotherapy-Resistant B-Precursor Acute Lymphoblastic Leukemia

Max S Topp, Gerhard Zugmaier, MD, Nicola Goekbuget, MD, Svenja Neumann, MD, Heinz-August Horst, MD, Thorsten Raff, MD, Monika Brueggemann, MD, Michael Kneba, MD, Andreas Viardot, MD, Mathias Schmid, MD, Markus Schaich, MD, Matthias Stelljes, MD, Mariele Goebeler, MD, Heike Pfeiffer, MD, Oliver Ottmann, MD, Thomas Burmeister, MD, Evelyn Degenhard, Margit Schmidt, PhD, Jürgen Scheele, MD, PhD, Hermann Einsele, MD, Peter Kufer, MD, Matthias Klinger, PhD, Dirk Nagorsen, MD, Dieter Hoelzer, MD, Ralf Bargou, MD
Journal: Blood
Blood (2010) 116 (21): 174.
https://doi.org/10.1182/blood.V116.21.174.174
Published: 2010